Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
by
Cong,Duanduan
, Liu,Xiaohui
, Qi,Wenyuan
, Xue,Wei
, Li,Kexin
, Xu,Xiaoyu
, Dong,Lingyun
in
acetylsalicylic acid
/ Aspirin
/ Aspirin - pharmacokinetics
/ Chromatography, Liquid
/ Clinical Trial Report
/ Cross-Over Studies
/ Delayed-Action Preparations - pharmacokinetics
/ Drug Design, Development and Therapy
/ East Asian People
/ enteric-coated sustained-release
/ Healthy Volunteers
/ Humans
/ pharmacokinetics
/ RM1-950
/ Salicylates
/ Salicylic Acid
/ Tablets, Enteric-Coated - pharmacokinetics
/ Tandem Mass Spectrometry
/ Therapeutics. Pharmacology
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
by
Cong,Duanduan
, Liu,Xiaohui
, Qi,Wenyuan
, Xue,Wei
, Li,Kexin
, Xu,Xiaoyu
, Dong,Lingyun
in
acetylsalicylic acid
/ Aspirin
/ Aspirin - pharmacokinetics
/ Chromatography, Liquid
/ Clinical Trial Report
/ Cross-Over Studies
/ Delayed-Action Preparations - pharmacokinetics
/ Drug Design, Development and Therapy
/ East Asian People
/ enteric-coated sustained-release
/ Healthy Volunteers
/ Humans
/ pharmacokinetics
/ RM1-950
/ Salicylates
/ Salicylic Acid
/ Tablets, Enteric-Coated - pharmacokinetics
/ Tandem Mass Spectrometry
/ Therapeutics. Pharmacology
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
by
Cong,Duanduan
, Liu,Xiaohui
, Qi,Wenyuan
, Xue,Wei
, Li,Kexin
, Xu,Xiaoyu
, Dong,Lingyun
in
acetylsalicylic acid
/ Aspirin
/ Aspirin - pharmacokinetics
/ Chromatography, Liquid
/ Clinical Trial Report
/ Cross-Over Studies
/ Delayed-Action Preparations - pharmacokinetics
/ Drug Design, Development and Therapy
/ East Asian People
/ enteric-coated sustained-release
/ Healthy Volunteers
/ Humans
/ pharmacokinetics
/ RM1-950
/ Salicylates
/ Salicylic Acid
/ Tablets, Enteric-Coated - pharmacokinetics
/ Tandem Mass Spectrometry
/ Therapeutics. Pharmacology
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
Journal Article
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
2023
Request Book From Autostore
and Choose the Collection Method
Overview
To study and compare the pharmacokinetic characteristics of enteric-coated sustained-release (EcSr) aspirin tablets with enteric-coated (Ec) aspirin tablets (Bayer S.p.A) in healthy Chinese participants.
In this open, randomized, single-dose, three-way, crossover study, 18 healthy participants randomly received 100 mg EcSr tablets pre-prandially (a.c.), EcSr tablets post-prandially (p.c.), or Ec tablets a.c. in each period. The concentrations of acetylsalicylic acid (ASA) and salicylic acid (SA) in plasma were determined by the LC-MS/MS method, and the pharmacokinetic parameters were calculated using WinNonlin (version 8.1).
The essential PK parameters under the three treatment conditions (ie Ec a.c., EcSr a.c. and EcSr p.c.) were as follows: C
: 758.38±455.34, 222.77±98.04 and 194.54±61.19 ng, T
: 6.75(2,16), 4.5(2,11) and 8.25(5,11) h, T
: 0.43±0.08, 1.44±0.59 and 4.32±10.04 h, AUC
: 1008.88±452.27, 918.04±238.40 and 845.55±183.25 h·ng/mL; C
: 6409.38±2098.52, 2863.53±679.73 and 2913.75±853.27ng/mL, T
: 7.25(2,24), 10(3.5-14) and 10(7,14) h, T1/2, SA: 2.21±0.46, 2.69±0.72 and 3.51±2.06h, AUC
: 29,131.41±9376.23, 27,243.97±7465.16, 27,240.25±7444.67 h·ng/mL. When taking EcSr aspirin tablets, the 90% confidence intervals of the geometric mean ratios (pre-prandial/post-prandial) of AUC
and AUC
, C
, AUC
and AUC
were within the range of 80.00%-125.00%.
EcSr aspirin tablets showed less inter-individual variation in release and absorption than Ec aspirin tablets, which was well reflected by comparing essential PK parameters. Furthermore, meals had no significant effect on the pharmacokinetics of EcSr aspirin tablets.
Publisher
Informa UK Limited,Dove Medical Press Limited,Dove,Dove Medical Press
This website uses cookies to ensure you get the best experience on our website.